SIFY vs OBX Comparison

Sify Technologies Ltd is the integrated information and communication technology (ICT) solutions and services companies in India, offering end-to-end solutions with a comprehensive Product offering delivered over a common network infrastructure. It is providing services to enterprise customers, comprising Network services, Data Center services, and Digital Services which represent its operating segments. Majority of revenue comes from Network services segment which focuses India Network Business, World'wide Network Business, Wholesale Voice, Retail Voice. Network services offers Secure Connect, Express Connect, Partner Connect, Data Center/Cloud Interconnect portfolio services. It has presence in India, and Rest of world. It generates maximum revenue from India.

Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.